NO20052710L - Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Info

Publication number
NO20052710L
NO20052710L NO20052710A NO20052710A NO20052710L NO 20052710 L NO20052710 L NO 20052710L NO 20052710 A NO20052710 A NO 20052710A NO 20052710 A NO20052710 A NO 20052710A NO 20052710 L NO20052710 L NO 20052710L
Authority
NO
Norway
Prior art keywords
group
optionally substituted
hydrogen atom
alkyl
processes
Prior art date
Application number
NO20052710A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Guy Bizot-Espiard
Sylvain Rault
Jean-Charles Lancelot
Pierre Renard
Daniel-Henri Caignard
Marina Kopp
Buno Pfeiffer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20052710L publication Critical patent/NO20052710L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20052710A 2002-11-05 2005-06-06 Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO20052710L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213802A FR2846656B1 (fr) 2002-11-05 2002-11-05 Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2003/003277 WO2004043957A1 (fr) 2002-11-05 2003-11-04 Derives d’imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
NO20052710L true NO20052710L (no) 2005-06-06

Family

ID=32104440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052710A NO20052710L (no) 2002-11-05 2005-06-06 Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (27)

Country Link
US (1) US7098220B2 (ru)
EP (1) EP1558612B1 (ru)
JP (1) JP2006508111A (ru)
KR (1) KR100717488B1 (ru)
CN (1) CN100335480C (ru)
AR (1) AR041882A1 (ru)
AT (1) ATE337317T1 (ru)
AU (1) AU2003292323A1 (ru)
BR (1) BR0315800A (ru)
CA (1) CA2504008A1 (ru)
CY (1) CY1105752T1 (ru)
DE (1) DE60307875T2 (ru)
DK (1) DK1558612T3 (ru)
EA (1) EA008446B1 (ru)
ES (1) ES2271653T3 (ru)
FR (1) FR2846656B1 (ru)
HK (1) HK1081964A1 (ru)
MA (1) MA27411A1 (ru)
MX (1) MXPA05004791A (ru)
MY (1) MY135191A (ru)
NO (1) NO20052710L (ru)
NZ (1) NZ539599A (ru)
PL (1) PL375373A1 (ru)
PT (1) PT1558612E (ru)
UA (1) UA80579C2 (ru)
WO (1) WO2004043957A1 (ru)
ZA (1) ZA200503234B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1754483A1 (en) 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
FR2903695B1 (fr) 2006-07-13 2008-10-24 Merck Sante Soc Par Actions Si Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2008016730A2 (en) * 2006-08-02 2008-02-07 Targeted Molecular Diagnostics, Llc Compositions and methods for reducing cellular fat
US8163505B2 (en) 2007-05-22 2012-04-24 The Penn State Research Foundation Methods using PBK1 for identifying agents that treat metabolic disorders
US8507473B2 (en) 2008-09-11 2013-08-13 Arena Pharmaceuticals, Inc. 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders
CA2737694C (en) * 2008-09-26 2013-07-02 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CN102264228A (zh) 2008-10-22 2011-11-30 默沙东公司 用于抗糖尿病药的新的环状苯并咪唑衍生物
US8329914B2 (en) * 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
WO2010103040A1 (en) 2009-03-10 2010-09-16 INSERM (Institut National de la Santé et de la Recherche Médicale) 5'-adenosine monophosphate-activated protein kinase (ampk) activators for treating pulmonary hypertension
JP2013510834A (ja) 2009-11-16 2013-03-28 メリテク ［１，５］‐ジアゾシン誘導体
WO2011106273A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
RU2635662C2 (ru) * 2010-09-10 2017-11-15 Сионоги Энд Ко., Лтд. Конденсированное с гетерокольцом имидазольное производное, обладающее активирующим амрк действием
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9527839B2 (en) 2012-08-22 2016-12-27 Merck Sharp & Dohme Corp. Benzimidazole tetrahydropyran derivatives
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
WO2014145852A2 (en) * 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
EP3572405B9 (en) 2014-09-12 2023-12-06 Biohaven Therapeutics Ltd. Benzoimidazol-1,2-yl amides as kv7 channel activators
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
ATE301120T1 (de) * 1996-12-11 2005-08-15 Aventis Pharma Inc Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid
WO2000012089A1 (en) * 1998-08-31 2000-03-09 Merck & Co., Inc. Novel angiogenesis inhibitors
US6271241B1 (en) * 1999-04-02 2001-08-07 Neurogen Corporation Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors

Also Published As

Publication number Publication date
CY1105752T1 (el) 2010-12-22
CN1711261A (zh) 2005-12-21
AU2003292323A1 (en) 2004-06-03
EP1558612A1 (fr) 2005-08-03
MXPA05004791A (es) 2005-07-22
ATE337317T1 (de) 2006-09-15
FR2846656A1 (fr) 2004-05-07
FR2846656B1 (fr) 2004-12-24
DE60307875T2 (de) 2007-04-12
CN100335480C (zh) 2007-09-05
ES2271653T3 (es) 2007-04-16
US20060069117A1 (en) 2006-03-30
HK1081964A1 (en) 2006-05-26
BR0315800A (pt) 2005-09-20
EA200500717A1 (ru) 2005-10-27
ZA200503234B (en) 2006-06-28
DK1558612T3 (da) 2006-12-27
PT1558612E (pt) 2006-12-29
EA008446B1 (ru) 2007-06-29
AR041882A1 (es) 2005-06-01
WO2004043957A1 (fr) 2004-05-27
CA2504008A1 (fr) 2004-05-27
DE60307875D1 (de) 2006-10-05
MY135191A (en) 2008-02-29
EP1558612B1 (fr) 2006-08-23
KR20050084663A (ko) 2005-08-26
JP2006508111A (ja) 2006-03-09
UA80579C2 (en) 2007-10-10
MA27411A1 (fr) 2005-06-01
KR100717488B1 (ko) 2007-05-14
US7098220B2 (en) 2006-08-29
NZ539599A (en) 2007-06-29
PL375373A1 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
NO20052710L (no) Nye imidazopyridinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20076006L (no) Acetylenderivater
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
NO20072632L (no) Oksadiazolderivater som DGAT-inhibitorer
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
HUP0401784A2 (hu) Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények
NO20076624L (no) Syklisk aminderivat med substituert alkylgruppe
NO20064326L (no) Aryl- og heteroarylpiperidinkarboksylatderivater, deres fremstilling og anvendelse derav i form av FAAH enzyminhibitorer
NO20081169L (no) Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20073283L (no) Nye pyridotienopyrimidinderivater
NO20062083L (no) Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20055167L (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
HUP0402500A2 (hu) Gyulladáskeltő citokinok kibocsátását gátló heterokondenzált pirazol-3-on vegyületek és az ezeket tartalmazó gyógyszerkészítmények
NO20091779L (no) Nye indolforbindelser en prosess for deres fremstilling og farmasoytiske sammensetninger som inneholder dem
NO20062100L (no) Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
MY140571A (en) Mercaptoimidazoles as ccr2 receptor antagonists
NO20065323L (no) 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav
CO6331309A2 (es) Derivados 6-heterociclico-imidazo[1,2-alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica
NO20064073L (no) Derivater fra 2H- eller 3H-benzo[e]indazol-1-yl-karbamat, deres fremstilling og terapeutisk anvendelse derav
TW200606155A (en) Mercaptoimidazoles as CCR2 receptor antagonists
NO20050572L (no) Nye benzo[b]kromeno-naftyridin-7-on- og pyrano[2',3':7,8]kino[2,3-b]kinoksalin-7-on-forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20080677L (no) Ny 1H-indol-pyridinkarboksamid og 1H-indol-piperidinkarboksamidforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger som inneholder dem
NO20031371L (no) Nye indolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20063462L (no) Nye polysubstituert 1,1-pyridylaminocyklopropanaminforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
DK1572198T3 (da) Farmaceutiske forbindelser med alfa2-receptoraktivitet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application